Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois Urbana-Champaign, IL, 61802 USA and Epivara, Inc., Research Park, 60 Hazelwood Dr., Suite 230G, Champaign, IL, 61820, USA.
MRC Centre for Reproductive Health, The Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.
Differentiation. 2021 Mar-Apr;118:41-71. doi: 10.1016/j.diff.2020.11.004. Epub 2020 Dec 13.
Estrogen has always been considered the female hormone and testosterone the male hormone. However, estrogen's presence in the testis and deleterious effects of estrogen treatment during development have been known for nearly 90 years, long before estrogen receptors (ESRs) were discovered. Eventually it was learned that testes actually synthesize high levels of estradiol (E2) and sequester high concentrations in the reproductive tract lumen, which seems contradictory to the overwhelming number of studies showing reproductive pathology following exogenous estrogen exposures. For too long, the developmental pathology of estrogen has dominated our thinking, even resulting in the "estrogen hypothesis" as related to the testicular dysgenesis syndrome. However, these early studies and the development of an Esr1 knockout mouse led to a deluge of research into estrogen's potential role in and disruption of development and function of the male reproductive system. What is new is that estrogen action in the male cannot be divorced from that of androgen. This paper presents what is known about components of the estrogen pathway, including its synthesis and target receptors, and the need to achieve a balance between androgen- and estrogen-action in male reproductive tract differentiation and adult functions. The review focuses on what is known regarding development of the male reproductive tract, from the rete testis to the vas deferens, and examines the expression of estrogen receptors and presence of aromatase in the male reproductive system, traces the evidence provided by estrogen-associated knockout and transgenic animal models and discusses the effects of fetal and postnatal exposures to estrogens. Hopefully, there will be enough here to stimulate discussions and new investigations of the androgen:estrogen balance that seems to be essential for development of the male reproductive tract.
雌激素一直被认为是女性激素,而睾丸激素是男性激素。然而,早在雌激素受体(ESR)被发现之前,人们就已经知道雌激素在睾丸中的存在及其在发育过程中治疗的有害影响近 90 年了。最终人们了解到,睾丸实际上合成高水平的雌二醇(E2),并将其在生殖道腔中隔离高浓度,这似乎与大量研究表明外源性雌激素暴露后生殖病理相矛盾。长期以来,雌激素的发育病理一直主导着我们的思维,甚至导致了与睾丸发育不良综合征相关的“雌激素假说”。然而,这些早期研究和 Esr1 敲除小鼠的发展导致了大量研究雌激素在男性生殖系统发育和功能中的潜在作用及其破坏作用。新的情况是,男性体内的雌激素作用不能与雄激素作用分开。本文介绍了雌激素途径的已知成分,包括其合成和靶受体,以及在男性生殖道分化和成年功能中实现雄激素和雌激素作用平衡的必要性。综述重点介绍了从睾丸网到输精管的男性生殖道发育的已知情况,并检查了雌激素受体在男性生殖系统中的表达和芳香化酶的存在,追溯了与雌激素相关的基因敲除和转基因动物模型提供的证据,并讨论了胎儿和产后暴露于雌激素的影响。希望这里有足够的信息来激发关于雄激素和雌激素平衡的讨论和新的研究,这种平衡似乎对男性生殖道的发育至关重要。